admin

Ontario funds rituximab for the treatment of relapsed Chronic Lymphocytic Leukemia (CLL)

Canadian Provinces Fund New Treatment for patients with indolent non-Hodgkin’s Lymphoma (iNHL) and Mantle Cell Lymphoma (MCL)